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Viable tissue sections and isolated cell cultures from the human fallopian tube, uterus, cervix, and vaginal
mucosa were examined for susceptibility to infection with human immunodeficiency virus type 1 (HIV-1). We
examined infectivity by using the monocytotropic strain HIV-1JR-FL and several primary isolates of HIV-1
obtained from infected neonates. HIV-1 infection was measured by p24 production in short-term culture and
by immunofluorescence detection of HIV-1 Nef and p24 proteins by laser scanning confocal microscopy.
Three-color immunofluorescence was used to phenotype HIV-infected cells within tissue sections from each
site. Our findings indicate that epithelial, stromal, and dendritic cells and cells with CD141 CD41, CD142
CD42, and CD41 CD142 phenotypes from the female reproductive tract are infectable with HIV-1. Of
importance is the finding that tissues from the upper reproductive tract are susceptible to infection with HIV-1.
Moreover, tissue samples from women in all stages of the menstrual cycle, including postmenopausal women
(inactive), could be infected with HIV-1. Female reproductive tract cells required a minimum of 60 min of
exposure to HIV-1 in order for infection to occur, in contrast to peripheral blood lymphocytes, which became
infected after being exposed to HIV-1 for only 1 min. These findings demonstrate that HIV-1 can infect cells
and tissues from different sites within the female reproductive tract and suggest that multiple cell types,
including epithelial cells, may be targets for the initial infection by HIV-1.
The rate of heterosexual transmission of human immunode-
ficiency virus type 1 (HIV-1) continues to increase worldwide.
In the United States, 40,000 to 80,000 new cases of HIV in-
fection occur each year (22), and it is estimated that 70% of
these occur via heterosexual transmission. Although female-
to-male transmission of HIV can occur, the vast majority of
cases involve transmission of virus or virus-infected cells from
male to female. HIV-1 can be transmitted either as free virions
or within infected cells (1, 3, 14, 19, 42, 48), although it is more
likely that infection is transmitted by virus-infected cells, as
these are present in higher numbers than free virus in seminal
fluid (20). Moreover, cell-to-cell contact within the female
reproductive tract is increased via factors such as prostaglan-
dins that are in high concentrations in semen (31).
Epidemiological studies established an association between
the presence of lesions or abrasions in the vagina or cervix and
an increased susceptibility to infection by HIV. This finding
suggested that HIV required direct contact with the circulation
for infection to occur. Moreover, this assumption helped to
explain the high level of heterosexual spread of HIV-1 in
Africa, where cervical ectopy and genital ulcers from venereal
diseases are associated with increased HIV seroprevalence (17,
25, 32), and in the United States, where herpes simplex and
syphilis infections correlated with an increased risk of HIV
transmission (15). In fact, HIV antigens were demonstrated in
monocyte-derived macrophages and endothelial cells within
the submucosa of cervical biopsy specimens from HIV-sero-
positive women who also were shown by immunohistochemis-
try to have cervicitis (33). In animal studies, transmission of
HIV has been reported in a chimpanzee inoculated with high
levels of cell culture-derived HIV directly into the vaginal
canal (10). Evidence obtained from cell culture studies sug-
gests that HIV is found within macrophages present in the
cervix and that these cells may function to transmit the virus to
other sites (26, 33). Infection of a cervical epithelial cell line by
infected lymphocytes and macrophages (39) and by free virions
(11) has also been demonstrated.
Despite these findings, little is known about the events sur-
rounding HIV-1 transmission and infection of the human fe-
male reproductive tract. It is well documented that virus can be
isolated from mucosal secretions from HIV-infected women
(33). Moreover, virus recovery is increased in pregnancy, dur-
ing oral contraceptive use, and in cervical ectopy (5, 13), sug-
gesting that hormone levels may regulate virus production
and/or infectivity. Mucosal epithelial cells may play an active
role in the infectivity of HIV-1, as studies of polarized epithe-
lial cells derived from a canine kidney cell line demonstrated
that the secretion of HIV-1 envelope glycoprotein is restricted
to the basolateral (serosal) surfaces (27). This finding suggests
that HIV-1 matures at the basolateral surface membrane and
provides a mechanism whereby HIV-1 can traverse epithelial
cells to gain entry into tissues and the systemic circulation by a
route other than by physical breakdown of the epithelium-
blood barrier.
We performed a systematic study of HIV-1 infectivity of
normal female reproductive tract tissues obtained from women
undergoing hysterectomy for various clinical conditions. The
overall goal of this study was to identify the types of cells within
the female reproductive tract that were susceptible to infection
with HIV-1 and the conditions under which infectivity could be
established. Our hypothesis is that epithelial cells lining the
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upper reproductive tract are susceptible to infection by HIV-1
and that once infected, they can transmit infection to T cells,
monocytes, and macrophages within the female reproductive
tract. Transmission of virus from infected epithelial cells to T
cells and monocytes/macrophages could explain how infection
is transmitted systemically, as T cells and myeloid cells traffic
between the reproductive tract and the periphery. In this study,
we examined infectivity of purified cultures of epithelial and
stromal cells as well as viable sections of tissues from the
fallopian tube, uterus, ectocervix, endocervix, and vagina and
demonstrated HIV infection of both epithelial and stromal
cells at multiple sites within the female reproductive tract,
including the upper tract. We also determined that reproduc-
tive tract epithelial cells require a longer time period of expo-
sure to HIV-1 than do peripheral blood lymphocytes for infec-
tion to occur. This prolonged time suggests that receptors
other than CD4 are involved in the initial stages of HIV in-
fection in these cells. These receptors may not be as efficient as
CD4 at binding and mediating internalization of virus. These
findings are the first to report infectivity of normal female
reproductive tract tissues and demonstrate that HIV can infect
cells in the upper reproductive tract. Moreover, these findings
have important implications for the pathophysiology of HIV
infection resulting from heterosexual transmission of virus.
MATERIALS AND METHODS
Source of tissues. Reproductive tract tissues were obtained immediately fol-
lowing surgery from 26 women who had undergone a hysterectomy for various
clinical conditions (Table 1). All tissues obtained and used in this study were
distal to the sites of pathology and were determined to be unaffected with disease
upon inspection by a trained medical technologist. Tissues obtained for study
were fallopian tube, uterus, ectocervix, endocervix, and vaginal mucosa, although
not all types of tissues were obtained from each patient.
Antibodies. Antibodies were obtained commercially and used for phenotypic
characterization of cells. Murine monoclonal antibodies were either unconju-
gated (rabbit anti-p24) or conjugated with fluorescein isothiocyanate (FITC),
phycoerythrin (PE), cyanin 3 (Cy3), or cyanin 5 (Cy5). Antibodies to leukocytes
included anti-CD4 (monocytes and lymphocytes), anti-CD14 (monocytes), anti-
HLA class II (Caltag, South San Francisco, Calif.), and anti-CD45 (pan-leuko-
cyte). Ber-EP4 (Dako, Carpinteria, Calif.) binds to an extracellular epithelial cell
protein (18), and anticytokeratin (pan-cytokeratin proteins 8 and 18, FITC con-
jugated; Sigma, St. Louis, Mo.) binds to an intracellular filament protein in
epithelial cells. Antivimentin (Cy3 conjugated; Sigma) binds to intracellular
filaments in stromal cells, fibroblasts, and leukocytes. Anti-HIV antibodies in-
cluded anti-Nef (FITC conjugated; Intracell, Cambridge, Mass.) and anti-p24
(Abbott Laboratories, Abbott Park, Ill.). Anti-Nef has been used to detect
infected cells in frozen sections of lymph nodes from HIV-1 infected individuals
(29).
Anti-CD4 (OKT4) was conjugated to Cy3 and anti-CD14 (AML-2-23) and
anti-HLA class II (IVA12) were conjugated to Cy5 in our laboratory. Antibodies
were purified from hybridoma cell culture supernatants (hybridoma cell lines
obtained from the American Type Culture Collection, Rockville, Md.) by using
HiTrap protein G-Superose columns (Pharmacia Biotech, Piscataway, N.J.) and
conjugated, where indicated, with Cy3 or Cy5 Fluorolink protein labeling kits
(Amersham, Arlington Heights, Ill.) according to the manufacturer’s recommen-
dations.
Cell and tissue preparation. Reproductive tract tissues obtained from hyster-
ectomy patients were placed immediately in sterile ice-cold phosphate-buffered
saline (PBS). Tissue specimens were dispersed by enzymatic digestion by using a
PHC enzyme mixture that contained final concentrations of 3.4 mg of pancreatin
(Gibco BRL, Grand Island, N.Y.), 0.1 mg of hyaluronidase (Worthington Bio-
chemical Corporation, Freehold, N.J.), 1.6 mg of collagenase (Worthington), and
2 mg of D-glucose per ml in 13 Hanks’ balanced salt solution (Gibco) containing
penicillin (50 U/ml) and streptomycin (50 mg/ml). Enzymes were chosen to
maximize digestion of the extracellular matrix while minimizing digestion of cell
surface antigens (43a). After mincing of tissues and incubation in PHC-Hanks’
balanced salt solution for 2 h at 378C, cells were dispersed through a 250-mm-
pore-size mesh screen, washed, resuspended in complete medium (Leibowitz
L-15 medium supplemented with 20 mM HEPES, 20 mg of gentamicin per ml, 2
mM L-glutamine, and 10% heat-inactivated fetal bovine serum [HyClone, Logan,
Utah]) and analyzed for cell number and viability. In some experiments, these
cells were plated directly into multiwell plates and allowed to adhere for 48 h,
and all nonadherent cells (including leukocytes) were removed by washing. This
cell preparation was termed mixed cells because it contained a mixture of epi-
thelial and stromal cells.
Epithelial cells were separated from stromal cells by serial filtration through
40- and 20-mm-pore-size nylon mesh filters (Small Parts Inc., Miami Lakes, Fla.).
TABLE 1. Patient characteristics and relevant medical historiesa
Patient no. Age (yr) Hormone therapy Diagnosis Menstrual cycle stage
346 46 Lupron Fibroids Proliferative
349 36 None Adenomyosis Proliferative
353 45 None Adenomyosis Mild hyperplasia
357 44 None Fibroids, adenomyosis Proliferative
359 50 None Uterine cancer Proliferative
364 41 None Premalignant ovarian tumor Inactive
372 31 Estrogen 1 progesterone Adenomyosis Secretory
387 37 None Fibroids Secretory
388 78 None Uterine cancer NDb
396 34 Unknown Premalignant ovarian tumor Proliferative
413 35 None Pelvic relaxation Secretory
421 37 None Fibroids Proliferative
422 52 None Endometriosis, fibroids ND
440 30 None Menorrhagiac Proliferative
449 46 Unknown Uterine cancer (stromal cell) ND
454 36 None Adenomyosis Secretory
468 42 None Fibroids, adenomyosis, endometriosis Proliferative
473 34 None Benign ovarian cyst Secretory
488 48 None Fibroids, endometriosis, fallopian tube inflammation Secretory
491 65 Unknown Benign ovarian cyst ND
502 53 None Endometriosis (bicornate uterus) Inactive
506 44 Unknown Adenomyosis Proliferative
513 39 None Fibroids Proliferative
518 40 None Fibroids Secretory
524 39 None Dysmenorrheac Secretory
527 51 None Ovarian cancer Inactive
a All patients described in this study are Caucasian.
b ND, not determined; in the two patients with ovarian cancer, menstrual cycle stage could not be determined due to the type of pathology.
c No pathological diagnosis was obtained.
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Epithelial cells were retained on the 40- and 20-mm-pore-size filters, while
stromal cells passed through the filters and were recovered in the effluent.
Epithelial cells were collected by inverting and washing the filters and were
plated in complete medium (containing serum) at 105 cells/well in 96-well mi-
crotiter plates (Costar, Cambridge, Mass.). Stromal cells were washed, resus-
pended in complete medium, and plated in 96-well microtiter plates at a con-
centration of 105 cells/well. Leukocytes and other cells were removed from these
cultures by washing out nonadherent cells after incubation for 24 h (stromal
cells) or 48 h (epithelial cells). Monocytes/macrophages were also washed out, as
these cells did not stick to plastic in the presence of serum-containing medium.
The remaining adherent cells were allowed to proliferate in complete medium.
It was not always possible to prepare stromal and/or epithelial cell cultures from
each patient because in some cases an insufficient amount of tissue was obtained.
We have summarized the tissue sites, types of cells studied, and results of HIV-1
infectivity studies for each patient in Table 2.
Purity of epithelial and stromal cells was evaluated by immunofluorescent
staining with lineage-specific antibodies and was performed on replicate wells
prior to each experiment. Determination of antibody binding was performed by
scanning wells containing stained cells by confocal microscopy. Positive and
negative cells were enumerated in areas representing approximately 200 cells.
Epithelial cell cultures exhibited uniform positive staining for the epithelial
antigens Ber-EP4 and cytokeratin and were negative for CD45 and vimentin.
Stromal cell cultures demonstrated strong positive staining for vimentin and were
negative for Ber-EP4 and CD45. Neither epithelial nor stromal cells express
CD4.
Additionally, we prepared fresh, unfixed, viable tissue sections for infectivity
studies. Blocks of freshly excised tissue were trimmed of excess fat and under-
lying musculature, and 30- to 70-mm sections were cut by using a vibratome
(VT1000; Energy Beam Sciences, Agawam, Mass.). Sections were maintained in
ice-cold PBS throughout processing, then transferred to wells of a 96-well plate
containing complete medium, and cultured for up to 15 days. Because vibratome
sectioning was performed on the bench, maintaining sterility was often difficult.
Thus, in some cases (Table 2), vibratome sections became contaminated with
fungus and could not be evaluated for infectivity. This problem was corrected
midway through the study when a new vibratome that could be used in a laminar
flow hood was obtained.
HIV-1 infection. Several strains of HIV-1 were used to determine susceptibility
to infectivity. HIV-1JR-FL, a monocytotropic laboratory strain that infects both T
cells and monocytes, was grown and its titer was determined as previously
described (7). Four pediatric isolates were isolated and characterized by John
Sullivan (University of Massachusetts, Worcester) and obtained from the NIH
AIDS Repository (Rockville, Md.). These strains, designated Rodro, Arilu,
Harwi, and Jamwi, were isolated from HIV-infected newborns who were infected
either in utero or at the time of birth. Pediatric isolates were propagated in
phytohemagglutinin (PHA) blasts, and titers were determined by endpoint dilu-
tion as described elsewhere (35). These strains infect primary cultures of mono-
cytes as well as T cells.
Infectivity of purified epithelial, stromal, or mixed cell cultures and of vi-
bratome sections was performed by adding 100 to 300 50% tissue culture infec-
tive doses (TCID50) of HIV-1 to microtiter wells containing the cells or tissue
section. In most experiments, virus was allowed to incubate with cells for 5 days,
followed by washing out the unbound virus by repetitive removal and replenish-
ment of serum-free medium (RPMI 1640) into each well. The cells were refed
with complete medium, and a sample of the medium removed for p24 determi-
nation (day 0). In experiments in which p24 levels were quantitated, PHA blasts
(105 cells) prepared from an allogeneic seronegative donor were added to one-
half of the replicate wells after the 5-day exposure to virus, and the medium was
supplemented with 10 IU of interleukin-2 (Boehringer Mannheim). PHA blasts
were prepared by culturing mononuclear cells for 72 h with 4 mg of PHA per ml
and then washed three times to remove PHA before culture. After 0, 5, and 10
days following PHA blast addition, 100 ml of supernatant representing one-half
of the volume from each well was collected and pooled from triplicate micro-
wells, and infectious virus was inactivated with 0.5% Triton. Each well was refed
with 100 ml of fresh medium following harvesting of supernatant.
To determine whether HIV-1 would stick nonspecifically to female reproduc-
tive tract cells and then infect PHA blasts that were subsequently added, semi-
confluent monolayers of LN-CaP cells, a human epithelial carcinoma cell line
derived from prostate (16), were incubated with HIV-1 in the same manner as
the female reproductive tract cell cultures, washed, and cocultured with PHA
blasts. Culture supernatant was collected on days 0, 5, and 10 after PHA blast
addition and tested for p24.
Time course of HIV-1 infectivity. Replicate cultures of uterine epithelial cells
were grown for 21 days to achieve 80% confluency and then infected for various
times from 1 min to 12 h with 300 TCID50 of HIV-1Harwi. Virus was added to
triplicate wells at specific time points, starting with the longest time period and
ending with the shortest time period. At the end of the incubation, all wells were
washed extensively to remove any unincorporated virus and incubated overnight
in complete medium, and PHA blasts were added. p24 levels were evaluated in
culture medium pooled from triplicate wells 10 days after addition of PHA blasts.
A similar study was performed to determine the minimum time of exposure to
HIV-1 necessary to infect peripheral blood T cells. For this study, PHA blasts
were prepared as described above, incubated with HIV-1Harwi for time periods
ranging from 1 to 60 min, washed extensively to remove any unincorporated
virus, and cultured in triplicate in wells of a 96-well microtiter plate. Cultures
were refed on day 5 postinfection, and supernatant collected on day 10 was
assayed for p24 by enzyme-linked immunosorbent assay (ELISA).
Determination of HIV-1 infectivity and immunophenotyping of cell cultures
and tissue sections. HIV-1 infection of cells and tissue sections was determined
by p24 antigen quantitation in supernatant by ELISA (HIVag kit; Abbott Lab-
oratories) and by immunofluorescence detection of intracellular viral antigens.
TABLE 2. Summary of results of HIV-1 infection of female reproductive tract cellsa
Patient no. Organ type Cell type Virus(es) HIV infectivity results
346 CX, ECX, VM Stromal JR-FL Not infected
FT Vibratome JR-FL, primaryb Infected
349 UT Stromal JR-FL, primary 1 of 2 cultures infected
UT Epithelial JR-FL, primary Infected
353 UT Stromal JR-FL Infected
357 UT Mixed cell Harwi Infected
FT Stromal Harwi Poor culture viability
359 UT Mixed cell JR-FL Infected
372 UT Stromal JR-FL, Rodro Infected
387 UT Stromal JR-FL, Jamwi 1 of 2 infected with Jamwi; 1 of 4 infected with JR-FL
388 FT Vibratome JR-FL Infected
413 UT Stromal Rodro, Jamwi Not infected
FT, ECX, CX Mixed cell JR-FL, Harwi Only FT infected
421 UT Mixed cell JR-FL, Harwi Infected
422 FT Vibratome JR-FL Infected
454 UT Stromal JR-FL, Harwi 1 of 2 cultures infected
UT Epithelial JR-FL, Harwi 3 of 4 cultures infected
468 UT, ECX, CX Vibratome Harwi 3 of 3 cultures infected
473 UT Epithelial Harwi Infected
502 UT, ECX, CX, FT Vibratome Harwi 4 of 4 cultures infected
527 UT, ECX, CX Epithelial Harwi 3 of 3 cultures infected
UT, ECX, CX Stromal Harwi 3 of 3 cultures infected
a HIV-1 infection was confirmed either by p24 production or by immunostaining. Samples from patients 440, 449, 506, 513, and 518 were contaminated with fungus
and could not be evaluated. Samples from patients 488, 491, and 524 could not be evaluated because of poor culture viability. Stromal cells from the fallopian tube
(FT), ectocervix (ECX), cervix (CX), and (VM) vaginal mucosa from patient 364 and vibratome samples from the fallopian tube, uterus, ectocervix, and cervix from
patient 396 were not infected with HIV-1.
b Primary indicates that all four primary isolates of HIV-1 (Jamwi, Rodro, Arilu, and Harwi) were used.
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For immunofluorescence staining, cells or tissue sections were first washed ex-
tensively in PBS containing 1% bovine serum albumin and 0.5% azide (PBA) to
remove extracellular viral particles and resuspended in PBA containing human
immunoglobulin (Ig; 6 mg/ml) to block nonspecific binding of antibodies to cells.
Then 1 mg of primary or isotype control fluorochrome-conjugated antibodies to
extracellular antigens was added, and the mixture was incubated for 30 min
(confluent cell cultures) or overnight (vibratome sections) at 48C in the dark with
continuous gentle agitation. Extracellular antigens included Ber-EP4, CD14,
HLA class II, and CD4. Combinations of Cy3-, Cy5-, and FITC-conjugated
antibodies to these antigens were used to obtain the most relevant phenotypic
information for each cell culture well or tissue fragment. Unbound antibody was
removed by aspiration followed by four 20-min washes in PBA. Washed sections
were then fixed overnight in PBA containing 1% paraformaldehyde. Intracellular
staining for expression of the intracellular antigen Nef, p24, vimentin, or cyto-
keratin was then carried out. After washing, cell and vibratome sections were
permeabilized by incubation for 2 h at 238C in 200 ml of Fix and Perm (Caltag)
in the presence of human Ig block and either primary antibody or a matched
FITC-labeled isotype control. Following this incubation, the cells and vibratome
sections were washed once in PBA containing 0.5% saponin, followed by two
additional washes in PBA. Cells stained with the unconjugated anti-p24 antibody
were then incubated with PE-conjugated goat anti-rabbit IgG antibody (Caltag)
for 30 min at 238C, followed by one wash with PBA-saponin and two washes with
PBA as described above. The negative control for rabbit anti-p24 was normal
rabbit serum at a 1:500 dilution. All cells and tissue fragments were then fixed in
1% paraformaldehyde and stored for up to 7 days before analysis.
Analysis by laser scanning confocal microscopy. Antibody-stained vibratome
sections were removed from the microwell and wet mounted in antifade (Mo-
lecular Probes, Eugene, Oreg.) on a standard glass microscope slide, sealed with
nail varnish, and analyzed for fluorescence on a Bio-Rad MRC 1024 laser
scanning confocal microscope equipped with a krypton-argon laser. Sections
exposed to HIV-1 were compared to identically treated sections that had not
been exposed to HIV-1. Vibratome sections stained with isotype-matched con-
trol antibodies were optically sectioned, and photomultiplier tube gain and en-
hancement factors were then determined for the FITC, Cy3, and Cy5 channels,
using these single fluorochrome-stained sections to ensure effective cross-chan-
nel compensation. The threshold of the FITC channel was set such that no
fluorescence was seen either in the isotype control-stained sections or in unin-
fected sections that had been stained with FITC-Nef. Each section was scanned
at a Z step setting of 2 mm until a representative image was obtained. The
resulting image files were then used to create three-color images of the infected
cells within the sections.
Confluent cultures of epithelial and stromal cells were analyzed for FITC or
PE fluorescence on a Meridian Ultima UV/VIS argon laser system with an
inverted microscope and stage scanning mechanism. Isotype control antibody-
stained wells were analyzed first to verify that there was no nonspecific staining
and that background levels of fluorescence were within acceptable levels. Anti-
body-stained wells were then analyzed, and dual images representing FITC and
PE were obtained. PMT settings were adjusted to minimize crossover between
fluorochromes. Images obtained by laser scanning confocal microscopy were
analyzed by using the Bio-Rad Laser Sharp Analysis software.
RESULTS
HIV infectivity of female reproductive tract cells and tis-
sues. Vibratome sections, purified cultures of epithelial and
stromal cells, and/or mixed cell cultures from different sites of
the female reproductive tract from 26 patients were evaluated
for the ability to become infected with HIV-1 in vitro. Samples
from 16 of the 26 patients studied showed evidence of in vitro
infection with HIV-1 as demonstrated by p24 production or by
immunofluorescence staining of HIV-1 viral proteins Nef
and/or p24. None of the samples from the 26 patients demon-
strated evidence of HIV-1 antigens prior to the addition of
HIV-1 in the laboratory. Of the 10 patients in whom HIV
infection could not be determined, cell cultures from 5 patients
could not be evaluated because of contamination with fungus
during the culture period, and cultures from 3 patients had low
cell yield or poor culture viability. Stromal cell cultures from
the fallopian tube, cervix, ectocervix, and vaginal mucosa from
patient 364 and vibratome sections from the fallopian tube,
cervix, ectocervix, and uterus from patient 396 did not demon-
strate evidence of infection although the culture was healthy
and viable throughout the 3 weeks of culture.
A summary of the 26 patients studied is shown in Table 1.
Patients ranged in age from 31 to 78 years and represented
proliferative, secretory, and inactive (postmenopausal) stages
of the menstrual cycle. One patient was on sex steroids, and
one was on Lupron therapy. The pathologic diagnoses were
identified to benign conditions in 20 of the patients, including
4 patients with endometriosis. Benign conditions also included
fibroids, adenomyosis, and benign ovarian cysts. Adenocarci-
noma of the uterus was diagnosed in two patients, stromal cell
carcinoma was diagnosed in one patient, and ovarian cancer
was found in one patient. Two patients had premalignant con-
ditions.
A range of tissue types demonstrated evidence of HIV in-
fection, including uterus (from 11 patients), fallopian tube (5
patients), cervix (3 patients), and ectocervix (3 patients). The
only site in which infectivity was not demonstrated was vaginal
mucosa, where samples from five patients were either contam-
inated (three cases) or did not become infected (two cases). In
some patients, there was variability in infectivity among differ-
ent cell types or cultures. For example, in patient 346 (Table
2), vibratome sections from the fallopian tube were infected
with HIV-1JR-FL, yet stromal cell cultures established from the
cervix, ectocervix, and vaginal mucosa were not infected. In
patient 387, two of six stromal cell cultures were infected with
virus, one with HIV-1Jamwi and one with HIV-1JR-FL. Only one
of the two stromal cell cultures from patient 349 demonstrated
infection with HIV-1.
Representative laser scanning confocal microscopic images
following immunofluorescence detection of HIV antigens in
cells and tissues from all five reproductive tract sites are shown
in Fig. 1. The sources of the cell and tissue samples are iden-
tified in the legend to Fig. 1. No binding of anti-Nef antibody
was seen in confluent cell cultures that were not infected with
HIV-1 (insets in Fig. 1e, f, h, and i) or in uninfected vibratome
sections (data not shown). Uterine and fallopian tube epithe-
lial cell cultures were dually stained with the epithelial cell-
specific antibody Ber-EP4, and stromal cell cultures were
stained with PE-antivimentin to verify cell lineage and homo-
geneity of these cultures. Stromal cell and epithelial cell cul-
tures exhibited uniform staining on 100% of the cells with their
respective lineage-specific antibodies (data not shown). Vi-
bratome sections stained with lineage-specific antibodies and
FITC–anti-Nef show that cells of multiple lineages are infected
with HIV. For example, in Fig. 1a, a cell expressing CD4 and
HLA class II displayed high reactivity with anti-Nef antibody.
Based on phenotyping and morphology, this cell is most likely
a macrophage. Figure 1b shows a cluster of cells that are
CD141 CD41 but Nef negative surrounding a smaller cluster
of CD142 CD42 Nef-positive cells. These nef-positive cells
could be either stromal, epithelial, or dendritic cells. In panel
c, a cell expressing CD4 and Nef and negative for CD14 most
likely represents a T cell. In Fig. 1d, a cell with dendritic
morphology negative for CD14 and CD4 was highly positive
for Nef.
p24 production by purified epithelial and stromal cells. Ini-
tial studies involved infecting cells with HIV-1 for 10 days
followed by analysis of p24 in culture supernatant. These stud-
ies demonstrated that p24 levels were often below the limit of
detection by ELISA, and so subsequent studies involved the
addition of PHA blasts to the cells on day 5 postinfection to
amplify virus production. For these studies, purified cultures of
stromal or epithelial cells were incubated with HIV-1 for 5
days and then extensively washed to remove all extracellular
virus particles. PHA blasts were then added to one-half of the
replicate wells, and p24 values were determined immediately
(day 0) and at 5 and 10 days after PHA blast addition (Table
3). p24 levels were all below the level of detection (,10 pg/ml)
immediately following the addition of blasts but increased
markedly 5 and 10 days after incubation with PHA blasts.
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To verify that p24 production reflected PHA blast infection
by uterine stromal or epithelial cells and was not due to non-
specific sticking of virus to the extracellular membrane of the
female reproductive tract cells or to the plastic wells, we per-
formed an identical study using purified cultures of epithelial
cells from a prostate carcinoma cell line, LN-CaP (16). As
shown in Table 3, LN-CaP cells infected identically to epithe-
lial and stromal cell cultures did not demonstrate any detect-
able levels of p24 10 days after PHA blast addition.
Vibratome sections from the fallopian tube were infected
with HIV-1JR-FL in a manner similar to that used with epithe-
lial and stromal cell cultures (Table 4). Due to the three-
FIG. 1. HIV infection of vibratome sections and purified cell cultures form the female reproductive tract. Vibratome sections or purified epithelial or stromal cell
cultures were infected with HIV-1 for 5 days, washed extensively, and then examined for expression of Nef and lineage-specific cell surface markers by immunoflu-
orescence and laser scanning confocal microscopy. Vibratome sections from fallopian tube (a) were stained with Cy5 (blue)–anti-HLA class II, Cy3 (red)–anti-CD4,
and FITC (green)–anti-Nef, and those from uterus (b), ectocervix (c), cervix (d), and vaginal mucosa (g) were stained with Cy5-CD14, Cy3-CD4, and FITC–anti-Nef.
The Nef-positive cell in panel a is most likely a monocyte/macrophage, as it is positive for both class II and CD4. Panel b shows a cluster of cells that are CD141 CD41
but Nef negative surrounding a smaller cluster of CD142 CD42 Nef-positive cells. The cell in panel c is negative for CD14 and positive for CD4 and Nef and is most
likely a T cell. The Nef-positive cell in panel d is a dendritic cell, based on morphology and negative staining for both CD4 and CD14. Purified cultures of epithelial
cells from the fallopian tube (e) and uterus (h) were uniformly positive for Nef staining, and uninfected cells from these sites were Nef negative (the inserts in panels
f and h show no fluorescence staining with anti-Nef antibody). Similarly, purified cultures of stromal cells from fallopian tube (f) and uterus (i) were also uniformly
positive for Nef staining. Uninfected stromal cells from these sites were Nef negative (inserts in panels f and i).
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dimensional nature of the tissue section, it was not possible to
completely eliminate all extracellular virus by washing. Thus,
day 0 p24 values are above the lower limit of detection, al-
though they are lower than values on days 5 and 10 after blast
addition. The values in the wells that did not receive PHA
blasts also increased over time, albeit at a much lower rate,
demonstrating that virus was being produced by these tissues
even in the absence of PHA blast amplification.
Time course of HIV infectivity. To further evaluate the ki-
netics of HIV infectivity, we performed a detailed time course
using uterine epithelial cells. As shown in Fig. 2a, virus pro-
duction from uterine epithelial cells amplified by PHA blasts
was first detected in cultures that were exposed to HIV-1 for 60
min. No virus production was detected in cultures that were
exposed to HIV-1 for less than 60 min (Fig. 2A). In contrast,
when we performed the same experiment with PHA blasts
alone rather than with uterine epithelial cells, virus production
on day 10 was observed in cells incubated with virus for only 1
min (Fig. 2B). In this study, PHA blasts were incubated with
HIV-1 for the times noted, washed extensively to remove un-
incorporated virus, and cultured for 10 days. p24 levels were
quantified in wells on day 10 by ELISA.
DISCUSSION
We performed a systematic study of HIV-1 infectivity of
normal cells and tissues from the female reproductive tract.
Purified epithelial cells, stromal cells, and tissue sections from
five sites within the female reproductive tract representing
both the upper and lower reproductive tract with the exception
of ovary were infected with either a laboratory strain or one of
four primary isolates of HIV-1 obtained from infected neo-
nates. The viable tissue sections allowed analysis of HIV-1
infectivity in situ, where tissue architecture is conserved and
physical relationships between different cell types is preserved.
HIV-1 infectivity was determined by using three-color immu-
nofluorescence and confocal microscopy and by measuring p24
TABLE 3. P24 production from purified cultures of stromal and
epithelial cells from the uterus infected with HIV-1a
Patient
no. Cell type Virus strain
p24 (ng/ml)
Day 0 Day 5 Day 10
349 Stromal JR-FL 0.005 97.8 NDb
353 ,0.01c 0.2 2.5
372 ,0.01 ,0.01 12.3
387 ,0.01 15.3 50
387 Jamwi ,0.01 6.18 49
372 Rodro ,0.01 63.3 97.2
372 ,0.01 54.2 84.4
413 ,0.01 ND 7.9
349 Epithelial Harwi ,0.01 17.6 ND
473 ,0.01 16.8 ND
LNCaP JR-FL ,0.01 ,0.01 ,0.01
,0.01 ,0.01 ,0.01
a Cells (uterine stromal, uterine epithelial, or LN-CaP) were plated in wells of
96-well plates and allowed to reach 75% confluency before being infected with
HIV-1. HIV-1 was added at 300 TCID50 per well and incubated with cells for 1
to 5 days. Each well was extensively washed to remove unincorporated virus, and
blasts were added to triplicate wells. p24 levels were sampled immediately after
blast cell addition (day 0 p24) and on days 5 and 10. p24 was not detected in
replicate wells that did not receive PHA blasts (data not shown).
b ND, not determined.
c Limit of detection of the p24 ELISA is 0.01 ng/ml.
TABLE 4. p24 production from vibratome sectionsa from the
fallopian tube infected with HIV-1
Virus strain
p24 concentration (ng/ml)
PHA blasts Day 0 Day 5 Day 10
JR-FL 1 2.6 26.1 190
2 2.6 6.2 27
Arilu 1 1.8 28.0 46.0
2 2.7 3.0 6.0
Harwi 1 2.7 30.0 137.0
2 2.7 3.0 7.0
Rodro 1 2.8 NDb 125.0
2 2.7 0.86 ND
a Vibratome sections from fallopian tube from patient 346 were infected with
HIV-1 and washed extensively on day 5. PHA blasts (105 cells) were added to
one-half of the replicate wells, and p24 was collected immediately after blast
addition (day 0) and on days 5 and 10 after blast addition.
b ND, not determined.
FIG. 2. Time course of HIV infectivity of uterine epithelial cells and periph-
eral blood T cells (PHA blasts). Purified uterine epithelial cells from patients 473
and 357 were infected with HIV-1Harwi for various times from 1 min to 12 h,
washed extensively, and cultured overnight prior to the addition of PHA blasts.
p24 levels were determined on day 10 of culture (A). In panel B, PHA blasts
alone were incubated with HIV-1Harwi for various times from 1 min to 60 min,
washed extensively to remove unincorporated virus, and cultured in triplicate
wells. p24 values were measured on day 10 of culture. The values in panel A
(mean 6 standard deviation) represent the average of two experiments using
cells from two different donors. Asterisks refer to p24 values of#10 pg/ml, which
is the lower limit of detection of the p24 ELISA. The values in panel B represent
a single experiment.
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production from cell cultures or tissue fragments. For analysis
of p24 production, PHA blasts were added to cells and tissue
fragments to amplify virus production, as the level of virus
produced by infected female reproductive tract cells is often
too low to measure by ELISA. This approach has been used to
amplify virus production in CD4-negative cells (40). In all
cases, infectivity was verified by immunofluorescence detection
of HIV-1 viral proteins.
Our findings demonstrate that purified cultures of both ep-
ithelial and stromal cells from the fallopian tube and uterus
can be infected directly with HIV-1. Moreover, a laboratory
strain of HIV-1, HIVJR-FL, as well as several primary pediatric
isolates were able to infect these cells. As neither stromal nor
epithelial cells from the female reproductive tract express
CD4, this finding suggests that these cells express other recep-
tors that mediate the binding and internalization of HIV-1 or
that virus is taken up nonspecifically, possibly by fluid-phase
pinocytosis, phagocytosis, or direct fusion. Others have shown
that HIV can infect CD4-negative cells of epithelial cell origin
from the gut and other tissues (9, 24, 49, 52). Moreover, galac-
tosyl ceramide has been suggested to be a putative receptor for
HIV on CD4-negative human colonic epithelial cells (50) and
may well be the receptor for virus entry within female repro-
ductive tract epithelial cells. Preliminary analysis of uterine
epithelial cell monolayers for neutral glycolipids has demon-
strated, however, that these cells express di- and triosylceram-
ides but no significant levels of galactosyl ceramide (51). These
findings suggest that epithelial and/or stromal cells may serve
as initial sites of HIV-1 infectivity and may potentially mediate
the transfer of virus throughout the female reproductive tract,
perhaps via T cells and monocytes/macrophages that then traf-
fic out of the reproductive tract into the periphery.
Infectivity of epithelial cells from the fallopian tube, uterus,
and cervix indicates that the entire reproductive tract is poten-
tially a target for HIV uptake and systemic spread. Others have
suggested that blood contact from the vaginal trauma of sexual
intercourse, or lesions within the vaginal canal or cervix result-
ing from sexually transmitted diseases, are portals of entry for
HIV (12, 17, 32, 41). Our findings suggest that if HIV travels
the length of the reproductive tract, then free virus and/or
cell-associated virus present in semen may infect at any site
along the tract independently of lesions or sites of trauma.
That virus could reach the upper reproductive tract under
normal physiological conditions is suggested by the finding that
a small number of poorly motile sperm can be found in the
fallopian tubes within minutes of vaginal deposition (37). It is
possible that virus or virus-infected cells could establish an
initial infection in cells within the fallopian tubes. Further
studies are needed to demonstrate that virus and/or virus-
infected cells present within semen reach the upper reproduc-
tive tract to infect cells beyond the cervix and vagina.
In other studies, we attempted to determine whether tissues
are susceptible to HIV-1 infection under conditions in which
the architecture of cells in the reproductive tract is maintained.
These studies were performed with viable tissue sections from
the female reproductive tract prepared in the absence of en-
zymatic treatment. Infectivity studies of vibratome sections
revealed the presence of HIV-1 in CD41 CD141 cells that had
that morphological characteristics of macrophages, in CD41
CD142 cells that were most likely lymphocytes, and in CD42
CD142 cells with dendritic cell morphology. Other CD42
CD142 cells in vibratome sections that were infected with
HIV-1 included epithelial and stromal cells. Thus, multiple cell
types of varied morphology and phenotype within the female
reproductive tract, in addition to epithelial and stromal cells,
are susceptible to HIV infection. These findings raise the pos-
sibility that the initial infection with HIV can occur in any
number of different cell types.
To define the minimum time interval of exposure to HIV-1
necessary for infection to occur, we incubated HIV-1 with
purified uterine epithelial cells for time intervals from 1 min to
12 h. Extensive washing followed by PHA blast addition al-
lowed determination of infectivity of cells incubated with virus
at each time point. HIV-1 infection was not detected in any
cultures in which virus remained in contact with the cells for
less than 60 min prior to washing. This finding suggests that
infectivity of uterine epithelial cells does not occur rapidly but
requires a somewhat prolonged contact between virus and
cells. This is in contrast to the kinetics of HIV infection of
peripheral blood T cells (PHA blasts), in which infection was
observed by day 10 in cells that had been exposed to virus for
only 1 min. The prolonged contact required for infection of
uterine epithelial cells may be due to virus binding to receptors
other than CD4 or to the internalization of virus by mecha-
nisms that are other than receptor mediated, mechanisms that
may not be as efficient as the binding of gp120 to CD4.
That some individuals become HIV positive following a sin-
gle exposure to virus, whereas others remain resistant to re-
peated challenge, indicates that factors beyond simple viral
contact with a particular mucosal cell are involved in infection
(4, 28, 32). For example, sex hormone and cytokine levels in
the microenvironment of the virus and target cell may influ-
ence viral infectivity. Although our studies indicate that sam-
ples of cells and tissues representing each stage of the men-
strual cycle could be infected with HIV, specific sex hormones
or cytokines may still affect the ability of HIV to infect female
reproductive tract cells. In studies using both human and ro-
dent models, we and others have found that sex hormone
changes during the reproductive cycle regulate both the com-
position and the function of immune cells throughout the fe-
male reproductive tract. For example, in the human, polymeric
Ig receptor levels in uterine secretions are low during the
proliferative phase of the menstrual cycle and are elevated
during the secretory phase, when serum progesterone and es-
tradiol levels are elevated (38). In contrast, IgA in cervical
secretions is lowest at midcycle when ovulation occurs, relative
to early proliferative and late secretory phases (36). Using a rat
model, we demonstrated that antigen presentation by cells in
the reproductive tract varies with the stage of the estrous cycle
and the site analyzed (34, 46, 47). For example, antigen pre-
sentation in the vagina by dendritic cells and macrophages is
suppressed by estradiol at midcycle (proestrus) at a time when
antigen presentation by epithelial cells in the uterus is en-
hanced (47). Endocrine balance influences both the composi-
tion and the capacity of uterine and vaginal cells to present
antigen (45). These events are closely regulated by sex hor-
mones to ensure perpetuation of the species and effective im-
mune protection against pathogens. It is against this endo-
crine-immune system interface that HIV has evolved to survive
and infect women upon exposure to virus in the female repro-
ductive tract.
As documented with several viral diseases, CD81 cytolytic T
cells (CTL) are thought to play a critical role in the contain-
ment of HIV infection (2, 30, 44). With the demonstration that
activated CD81 T cells derived from peripheral blood secrete
one or more suppressive factors (21), it is highly likely that
CD81 T cells in the reproductive tract contribute to the control
of HIV infection in vivo. We have recently found that whereas
CD31 CD81 cells are present in the fallopian tube, uterus,
cervix, and vagina throughout the menstrual cycle, these cells
in the uterus are noncytolytic during the secretory phase of the
menstrual cycle when progesterone levels are highest and when
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fertilization and implantation are most likely to occur (43). In
contrast, CTL activity is higher in the uterus in postmeno-
pausal women than in premenopausal women during the men-
strual cycle. Should reproductive tract CD81 T cells produce
RANTES, MIP-1a, or MIP-1b, which have been identified as
major suppressive factors produced by peripheral blood CD81
T cells (6), then we would postulate that HIV infection would
be more easily established at the uterine level in women during
the secretory phase of the menstrual cycle. Whether uterine
CD81 T cells produce suppressive factors remains to be de-
termined. What is clear is that the endocrine regulation of the
mucosal immune system in the female reproductive tract in-
fluences immune cell function that has the potential for either
enhancing or suppressing the heterosexual transmission of
HIV. Indeed, a recent report by Marx and coworkers (23)
showed that primates that were given progesterone were more
likely to contract simian immunodeficiency virus infection after
vaginal challenge compared to placebo-treated animals, which
suggested that women on progestin-containing birth control
may be at higher risk for HIV infection (8, 23). This study
concluded that the increased susceptibility to SIV infection was
most likely due to the thinning of the vaginal wall by proges-
terone, which allowed for virus to penetrate the vaginal mu-
cosae more easily. However, our studies demonstrating lower
CTL activity in the uterus during the secretory stage of the
menstrual cycle, in which progesterone levels are highest (43),
suggest that the negative regulatory effect of progesterone on
immune cell function in the reproductive tract is more likely to
have been responsible for a higher incidence of infection after
viral challenge.
While much remains to be understood about the events
surrounding the heterosexual transmission of HIV, our finding
that multiple cells and tissues in the female reproductive tract
are susceptible to HIV infection provides a foundation to more
fully define the mechanisms involved in virus transmission as
well as approaches for inducing protection against viral spread.
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